Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer-Reference-Cited by-同舟云学术

Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer

Published:2019-01 Issue:1 Volume:37 Page:1-11
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Bazargani Soroush T.^ORCID,Clifford Thomas G.,Djaladat Hooman,Schuckman Anne K.,Wayne Kevin,Miranda Gus,Cai Jie,Sadeghi Sarmad,Dorff Tanya,Quinn David I,Daneshmand Siamak^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference30 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer;Meeks;Eur Urol,2012

3. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

4. Assessing cancer progression and stable disease after neoadjuvant chemotherapy for organ-confined muscle-invasive bladder cancer;Chappidi;Urology,2017

5. Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: predicting response and assessing outcomes;Gandhi;Urol Oncol,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Antigen 125 Expression Enhances the Gemcitabine/Cisplatin-Resistant Tumor Microenvironment in Bladder Cancer;The American Journal of Pathology;2023-03

2. CA125 for the Diagnosis of Advanced Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis;Cancers;2023-01-28

3. Predictive Biomarkers of Response to Neoadjuvant Therapy in Muscle Invasive Bladder Cancer;Urothelial Carcinoma;2023

4. Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer;Cancers;2022-12-28

5. Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder;Current Opinion in Urology;2022-07-15